Compare VTRS & SUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTRS | SUI |
|---|---|---|
| Founded | 1961 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8B | 15.5B |
| IPO Year | 2019 | 1996 |
| Metric | VTRS | SUI |
|---|---|---|
| Price | $16.35 | $132.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 13 |
| Target Price | $11.83 | ★ $137.46 |
| AVG Volume (30 Days) | ★ 9.2M | 803.7K |
| Earning Date | 05-27-2026 | 05-26-2026 |
| Dividend Yield | 2.98% | ★ 3.14% |
| EPS Growth | N/A | ★ 1426.76 |
| EPS | N/A | ★ 10.84 |
| Revenue | ★ $14,739,300,000.00 | $2,306,100,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.60 | $5.23 |
| P/E Ratio | ★ N/A | $13.52 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.85 | $109.22 |
| 52 Week High | $16.47 | $137.77 |
| Indicator | VTRS | SUI |
|---|---|---|
| Relative Strength Index (RSI) | 77.36 | 65.54 |
| Support Level | $9.63 | $124.98 |
| Resistance Level | $16.30 | N/A |
| Average True Range (ATR) | 0.46 | 2.78 |
| MACD | -0.02 | 0.45 |
| Stochastic Oscillator | 83.33 | 86.50 |
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
Sun Communities is a residential REIT that focuses on owning manufactured housing and residential vehicle communities. The company currently owns a portfolio of 501 properties, which includes 337 manufactured housing communities and 164 residential vehicle communities. Sun targets owning properties that are desirable as second homes or vacation properties with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.